|1.||Dichek, Helén L: 2 articles (11/2007 - 09/2004)|
|2.||Agrawal, Nalini: 2 articles (11/2007 - 09/2004)|
|3.||Qian, Kun: 2 articles (11/2007 - 09/2004)|
|4.||Chen, Y Z: 1 article (01/2014)|
|5.||Liu, H K: 1 article (01/2014)|
|6.||Yin, Z: 1 article (01/2014)|
|7.||Chen, J: 1 article (01/2014)|
|8.||Lin, N: 1 article (01/2014)|
|9.||Lin, H: 1 article (01/2014)|
|10.||Yu, X Y: 1 article (01/2014)|
11/01/2007 - "Reduced atherosclerosis in chow-fed mice expressing high levels of a catalytically inactive human hepatic lipase."
09/01/2004 - "These studies demonstrate that high levels of catalytically active human hepatic lipase (HL) reduce atherosclerosis, whereas high levels of a catalytically inactive HL do not affect atherosclerosis in mice genetically deficient in low-density lipoprotein receptor and mouse HL."
|2.||Hepatocellular Carcinoma (Hepatoma)
06/01/1999 - "Circulating human hepatic lipase mRNA in patients with hepatocellular carcinoma and healthy controls."
06/01/1999 - "To evaluate circulating human hepatic lipase mRNA as an indicator of circulating hepatoma cells by reverse transcriptase-polymerase chain reaction (RT-PCR) in patients with hepatocellular carcinoma (HCC). "
05/06/1994 - "Rat hepatoma McA-RH7777 cells transfected with a human hepatic lipase (HL) cDNA synthesized and secreted 50-80 ng of human HL/mg of cell protein at 4 h, approximately 50% of which was bound to cell-surface heparan sulfate proteoglycans (HSPG). "
|1.||LDL Receptors (LDL Receptor)
|2.||Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
|3.||Complementary DNA (cDNA)
|4.||Messenger RNA (mRNA)
|5.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|7.||Lipase (Acid Lipase)